Delivery Order SPE2DB22D1017-SPE2DB25FG8FE
- Not listed
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $18,543.22 to AmerisourceBergen Drug Corp for the supply of Sprycel 70 mg tablets (60-count units). This competitive award, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, utilizes firm fixed pricing with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Sprycel 140 mg tablets (30-count units) under a firm fixed-price contract. The delivery order, valued at $5,570.37 with a completion date of July 29, 2025, represents a competitive award with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,013.24 on July 25, 2025, for the supply of Sprycel 100 mg tablets (30-count packages). This competitively awarded, firm fixed-price contract is non-set-aside and specifies a completion date of July 28, 2025, with performance to be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,013.24 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count packaging) on June 9, 2025, with a completion date of June 10, 2025. This firm fixed-price, non-set-aside delivery order was issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026. The...
- The Defense Logistics Agency awarded a $5,777.71 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Sprycel 80 mg tablets (30-count). This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The performance location is listed as Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a delivery order valued at $12,785.44 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This firm fixed price, non-set-aside contract is classified as a delivery order and will be performed at the contractor's location in Conshohocken, Pennsylvania. Sprycel is a targeted cancer therapy medication, reflecting the Defense Logistics Agency's ongoing...
- The Defense Logistics Agency awarded a $16,591.33 delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) under a firm fixed-price contract. The award was made on July 22, 2025, with an ultimate completion date of July 23, 2025, and represents a non-competitive set-aside delivery against AmerisourceBergen's existing pharmaceutical supply contract vehicle. Performance will be executed from the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $38,472.49 to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count packages) under a firm fixed-price contract type. The award was made on August 29, 2025, with an ultimate completion date of September 2, 2025, and represents a non-competitive delivery order against an existing contract vehicle. Performance will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) under a firm fixed-price contract valued at $35,010.98. The award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-competitive delivery order executed without set-aside designation. Performance of this pharmaceutical supply contract will be fulfilled from AmerisourceBergen's Corporate Office location...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Sprycel 100 mg tablets (30-count units) with a ceiling value of $41,700.72. This firm fixed-price delivery order, awarded on August 28, 2025, represents a non-competitive, non-set-aside procurement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. As a child contract, this delivery order...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG8FEDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,578.09 to AmerisourceBergen Drug Corp for Sprycel 50 mg tablets (60-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price contract represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. Sprycel (dasatinib) is a targeted cancer therapy used in hematologic malignancies, consistent with the company's extensive portfolio of specialty medications supplied through the DLA Medical Supply Chain. The delivery order fulfills immediate pharmaceutical needs for the Defense Health Agency and related government healthcare systems. This award exemplifies the operational efficiency of the DLA's pharmaceutical prime vendor model, enabling rapid procurement of essential specialty medications to support military medical readiness and beneficiary care.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/25/25 |